C. M. Pedersen, M. Bols / Tetrahedron 61 (2005) 115–122
121
Compound 9b. Clear syrup, 1H NMR (D2O): d 3.0 (bd, JZ
12.8 Hz, 1H, H6e), 2.74 (dq, JZ6.4, 10 Hz, 1H, H2a), 2.6 (dt,
JZ2.8, 12.4 Hz, 1H, H6a), 2.08 (ddd, JZ3.6, 10.0, 10.4 Hz,
1H, H3a), 1.9 (bdd, JZ2.8, 13.6 Hz, 1H, H4e), 1.72 (dt, JZ
2.8, 13.2 Hz, 1H, H5e), 1.55 (dq, JZ2.8, 13 Hz, 1H, H4a),
1.42 (tq, JZ2.8, 13 Hz, 1H, H5a), 1.02 (d, JZ6.4 Hz, 3H,
CH3). (hydrochloride): d 3.06 (bd, JZ12.8 Hz, 1H, H6e),
2.94 (dq, JZ6.4, 10.8 Hz, 1H, H2a), 2.65 (dt, JZ2.5,
12.4 Hz, 1H, H6a), 2.19 (dt, JZ3.6, 10.8 Hz, 1H, H3a), 1.69
(bd, JZ11.6 Hz, 1H, H4e), 1.62 (bd, JZ13.6 Hz, 1H, H5e),
1.39 (ddd, JZ3.2, 13.2 Hz, 1H, H5a), 1.32 (dq, JZ3.2,
11.4 Hz, 1H, H4a), 0.95 (d, JZ6.4 Hz, 3H, –CH3). 13C NMR
(CD3OD): d 180 (C]O), 53 (C2), 50 (C6), 45 (C3), 27 (C4),
23 (C5), 19 (–CH3). (hydrochloride): d 175.5 (C]O), 52.9
(C2), 43.9 (C6), 42.8 (C3), 24.7 (C4), 20.1 (C5), 15.6 (–CH3).
IR (KBr, hydrochloride): 1613 (–CONH2), 1667 (–C]O),
2807 (R2NCH2), 2950 (C–H sp3), 3368/3180 (–CONH2).
MS: Calcd for C7H14N2O (MCH): 143.1184. Found:
143.1086.
Compound 11a. Syrup, 1H NMR (D2O/CD3OD): d 3.2 (bd,
JZ12.2 Hz, 1H, H6e), 2.97 (m, 1H, H3e), 2.85 (dq, JZ6.4,
3 Hz, 1H, H2a), 2.65 (ddd, JZ4, 10.4, 12.2 Hz, 1H, H6a),
2.05 (bd, JZ13 Hz, 1H, H4e), 1.55–1.85 (m, 3H, H4a, H5e,
H5a), 1.24 (d, JZ6.4 Hz, 3H, –CH3). (hydrochloride) d 3.55
(dq, JZ3.7, 6.0 Hz, 1H, H2a), 3.45 (bd, JZ3.7 Hz, 1H, H3e),
3.42 (dd, JZ3, 13 Hz, 1H, H6e), 3.05 (dt, JZ3.6, 12 Hz, 1H,
H6a), 2.18 (m, 1H, H4e), 1.7–2.1 (m, 3H, H4a, H5e, H5a), 1.45
(d, JZ6.4 Hz, 3H, –CH3). 13C NMR (CD3OD): d 121.8
(–C^N), 52.9 (C2), 46.5 (C6), 35.0 (C3), 28.3 (C4), 22.9
(C5), 20.7 (–CH3). (hydrochloride): dZ118.7 (–C^N), 52.5
(C2), 45.1 (C6), 33 (C3), 26.2 (C4), 20.1 (C5), 17.7 (–CH3).
IR (KBr, hydrochloride): 2242 (–C^N), 2700–2800
(R2NCH2), 2940 (C–H sp3). For MS the N-acetate was
prepared by treatment of 8–10 mg sample with 2 mL acetic
anhydride/CH2Cl2 (1:1) for 18 h and evaporating. MS
(N-acetate): Calcd for C9H14NO (MCNa)Z189.1004,
Found: 189.1006.
Compound 11b. Syrup, 1H NMR (D2O): d 3.92 (dt, JZ2.4,
12.8 Hz, 1H, H6e), 2.75 (dq, JZ6.4, 10.4 Hz, 1H, H2a), 2.53
(dt, JZ2.8, 12.4 Hz, 1H, H6a), 2.35 (ddd, JZ3.6, 10.4,
10.4 Hz, 1H, H3a), 2.16 (m, 1H, H5e), 1.58–1.75 (m, 2H,
H4a, H4e), 1.33 (m, 1H, H5a), 1.20 (d, JZ6.4 Hz, 3H, –CH3).
(hydrochloride) d 3.56 (dq, JZ6.56, 11.2 Hz, 1H, H2a), 3.47
(bd, JZ12.9 Hz, 1H, H6e), 3.08 (dd, JZ3.6, 13.2 Hz, 1H,
H6a), 3.04 (dd, JZ3.6, 11.2 Hz, 1H, H3a), 2.34 (ddq, JZ1.6,
3.6, 13.6 Hz, 1H, H4e), 2.05 (dk, JZ3.6, 14.4 Hz, 1H, H5e),
1.95 (ddd, JZ3.6, 12, 12 Hz, 1H, H4a, 1.76 (m, 1H, H5a).
13C NMR (CD3OD): d 121.8 (–C^N), 52.6 (C2), 44.1 (C6),
35.0 (C3), 26.7 (C4), 24.6 (C5), 17.8 (–CH3). (hydrochlor-
ide): dZ118.7 (–C^N), 53.1 (C2), 42.7 (C6), 32.7 (C3),
25.0 (C4), 20.1 (C5), 15.9 (–CH3). IR (KBr): 2254 (–C^N),
2650–2750 (R2NCH2), 2939 (C–H sp3). For MS the
N-acetate was prepared by treatment of 8–10 mg sample
with 2 mL acetic anhydride/CH2Cl2 (1:1) for 18 h
and evaporating. MS (N-acetate): Calcd for C9H14NO
(MCNa)Z189.1004, Found: 189.1005.
4.1.9. cis- and trans-N-tert-Butoxycarbonyl-3-cyano-2-
methylpiperidine (10a and 10b). Compound 8a or 8b
(0.58 g, 2.4 mmol) was dissolved in DCM (7 mL) and
DMSO (0.27 mL, 0.30 g; 3.8 mmol) was added. The
mixture was cooled to K78 8C and oxalylchloride
(0.25 mL, 0.37 g; 2.88 mmol) was added. After 15 min
triethylamine (1.0 mL, 0.73 g; 7.19 mmol) was added
dropwise. After further 15 min of stirring, the reaction
was quenched with 15 mL water and extracted with three
times 15 mL EtOAc. The organic layer was washed with
concd NaCl solution, dried over MgSO4 and concentrated.
Purification by chromatography—eluent DCM/EtOAc
50:1—gave 480 mg 10a or 10b (93%).
Compound 10a. White crystals. mpZ61 8C. 1H NMR
(CDCl3): (assigned using Cosy) d 4.64 (dq, JZ3.5, 6.6,
6.6, 6.6 Hz, 1H, H2e), 3.95 (bd, JZ13.2 Hz, 1H, H6e), 2.80
(dt, JZ3.3, 13.2, 13.2 Hz, 1H, H6a), 2.76 (dt, JZ3.5, 3.5,
11.5 Hz, 1H, H3a), 1.9–2.1 (m, 1H, H4e), 1.90 (ddd, JZ3.5,
13.2, 13.2 Hz, 1H, H4a), 1.70 (ddd, JZ2.0, 3.3, 13.2 Hz, 1H,
H5e), 1.46 (s, 9H, Boc), 1.38 (m, 1H, H5a), 1.31 (d, JZ
6.6 Hz, 3H, –CH3) 13C NMR (CDCl3): d 155 (Boc C]O),
120.5 (–C^N), 80.5 (–O–C(CH3)3), 47 (C6), 37.5 (C2), 31.7
(C3), 28.6 (O–C(CH3)3), 24.5 (C5), 23.0 (C4), 12.4 (–CH3).
IR (KBr): 1690 (C]O), 2240 (–C^N), 2977 (C–H sp2).
MS: Calcd for C12H22N2O3 (MCNa)Z247.1422. Found:
247.1415.
4.1.11. Determination of pKa of piperidine hydrochlor-
ides. The piperidine hydrochloride (30 mg) was dissolved in
15–20 mL distilled water and subjected to titration with
0.1 M NaOH following the pH with a pH electrode. The pKa
was determined from the resulting titration curve, and was
the average of three determinations (errorG0.1).
Compound 10b. White crystals. mpZ69 8C. 1H NMR
(CDCl3): (assigned using Cosy) d 4.63 (q, JZ6.8 Hz, 1H,
H2e),3.99(bd,JZ14 Hz, 1H, H6e),2.75(dt,JZ3.5,13, 13 Hz,
1H, H6a),2.63(bs,1H, H3e),1.81(m, 1H, H4e),1.75(tt,JZ3.6,
13 Hz, 1H, H4a), 1.58 (m, 1H, H5e), 1.41 (s, 9H, Boc), 1.22 (m,
1H, H5a), 1.15(d, JZ6.8 Hz, 3H, –CH3). 13C NMR (CDCl3):d
155 (Boc C]O), 120.5 (–C^N), 80.5 (–O–C(CH3)3), 48
(C6), 38 (C2), 31.6 (C3), 28.5 (O–C(CH3)3), 21.8 (C5), 21.6
(C4), 15.6 (–CH3). IR (KBr): 1693 (C]O), 2239 (–C^N),
2977 (C–H sp3). MS: Calcd for C12H22N2O3 (MCNa)
247.1422, Found: 247.1430.
References and notes
1. Alder, R. W.; Baker, R.; Brown, J. M. Mechanisms in Organic
Chemistry; Wiley: London, 1971.
2. Hammett, L. P. Chem. Rev. 1935, 17, 125–136.
3. Taft, R. W. J. J. Am. Chem. Soc. 1957, 79, 1045–1049.
4. Topsom, R. D. Prog. Phys. Org. Chem. 1976, 12, 1–20.
5. Grob, C. A.; Schlageter, M. G. Helv. Chim. Acta 1976, 59,
264–276.
6. Grob, C. A.; Rich, R. Helv. Chim. Acta 1979, 62, 2793–2801.
7. Clark, J.; Perrin, D. D. Q. Rev. 1964, 18, 295–320.
8. Inouye, S. Chem. Pharm. Bull. 1968, 16, 1134–1137.
9. Jensen, H. H.; Lyngbye, L.; Bols, M. Angew. Chem., Int. Ed.
2001, 40, 3447–3449.
4.1.10. cis- and trans-3-Cyano-2-methylpiperidine (11a
and 11b). Compound 11a or 11b were prepared from 10a or
10b as described for 9 above.